Back Knudsen, LB, Nielsen, PF, Huusfeldt, PO, et al (2000) 'Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration', Journal of Medicinal Chemistry , 43, 1664-69
PMID: 4 PopovJFarbodYChauhanUKalantarMHillLArmstrongDet al
Your provider may discuss which format aligns with your adherence preferences, insurance approval timeline, and clinical goals
In summary, GLP-/GIP dual agonists have shown superior potential over GLP-1 in improving lipid metabolism
For the study, researchers collected information from 411 participants taking GLP-1 medications on potential changes to their sense of taste, appetites, satiety, and food cravings after starting treatment